The stock price for 10x Genomics Inc. (TXG) currently stands at $53.32. The stock experienced a substantial increase in the last session, hitting $57.10 after starting at $55.93. The stock’s lowest price was $52.59 before closing at $57.10.
The market performance of 10x Genomics Inc.’s stock has been harmonious in recent times. Over the last year, the company’s stock reached its highest point at $58.30 on 05/22/23, while the lowest value for the same duration was $23.81 on 10/24/22.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Sponsored
52-week price history of TXG Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. 10x Genomics Inc.’s current trading price is -8.54% away from its 52-week high, while its distance from the 52-week low is 123.94%. The stock’s price range during the 52-week period has remained between $23.81 and $58.30. In the Healthcare sector, the company’s shares saw a trading volume of around 1.27 million for the day, which was evidently higher than the average daily volume of 0.86 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
10x Genomics Inc. (TXG) has experienced a quarterly rise of 9.11% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 6.16B and boasts a workforce of 1243 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 48.90, with a change in price of +21.64. Similarly, 10x Genomics Inc. recorded 983,473 in trading volume during the last 100 days, posting a change of +68.31%.
Examining TXG’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for TXG stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
TXG Stock Stochastic Average
10x Genomics Inc.’s raw stochastic average for the past 50 days is presently 56.51%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 38.37%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 69.68% and 73.73%, respectively.
TXG Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. This year’s metric has recorded a Price increase of 46.32%. However, over the past six months, we’ve seen a weaker performance of 51.01%. The price of TXG leaped by -1.75% over the last 30 days. And in the last five days, it has surged by 2.18%.
